» Articles » PMID: 32171475

Vitamin D Deficiency in Pediatric Patients Using Antiepileptic Drugs: Systematic Review with Meta-analysis

Overview
Specialty Pediatrics
Date 2020 Mar 16
PMID 32171475
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To measure the prevalence of vitamin D deficiency (through the 25-hydroxyvitamin D metabolite) in pediatric patients using antiepileptic drugs.

Source Of Data: Meta-analysis of studies identified through search in the PubMed, Embase, LILACS, and Cochrane Library databases, on February 19, 2019.

Summary Of Data: A total of 748 articles were identified, 29 of which were relevant to the objectives of this study. The prevalence of vitamin D deficiency found was 0.32 (95% CI=0.25-0.41; I=92%, p<0.01). In the subgroup analyses, the most significant results were observed in the group of patients using cytochrome P450-inducing antiepileptic drugs, with a prevalence of 0.33 (95% CI=0.21-0.47; I=86%, p<0.01) and, considering the study design, in the subgroup of cohort studies, with a prevalence of 0.52 (95% CI=0.40-0.64; I=76%, p<0.01).

Conclusions: Taking into account the deleterious effects of vitamin D deficiency on the bone health of individuals using antiepileptic drugs, it is suggested to include in their care 25-hydroxyvitamin D monitoring, cholecalciferol supplementation, and treatment of the deficiency, when present.

Citing Articles

Vitamin D status of pediatric epilepsy patients and evaluation of affecting factors.

Bilge S, Taskin S Ital J Pediatr. 2025; 51(1):39.

PMID: 39924499 PMC: 11809102. DOI: 10.1186/s13052-025-01898-9.


Hypovitaminosis D in university workers in Southern Ecuador: interactions between gender and lifestyle.

Diaz P, Cadena M, Montalvan M, Garrochamba K, Calderon P, Carrion G Front Nutr. 2024; 11:1482910.

PMID: 39391680 PMC: 11464991. DOI: 10.3389/fnut.2024.1482910.


Causal links between serum micronutrients and epilepsy: a Mendelian randomization analysis.

Chen H, Zheng Z, Cai X, Gao F Front Neurol. 2024; 15:1419289.

PMID: 39076846 PMC: 11284170. DOI: 10.3389/fneur.2024.1419289.


Comparison of 25-hydroxy vitamin D serum levels among children with epilepsy in therapy with single versus multiple antiseizure medications.

Gunawan P, Rochmah N, Faizi M Epilepsy Behav Rep. 2023; 24:100620.

PMID: 37680766 PMC: 10481176. DOI: 10.1016/j.ebr.2023.100620.


Prevalence and Related Risk Factors of Vitamin D Deficiency in Saudi Children with Epilepsy.

Al Khalifah R, Hamad M, Hudairi A, Al-Sulimani L, Al Homyani D, Al Saqabi D Children (Basel). 2022; 9(11).

PMID: 36360424 PMC: 9688346. DOI: 10.3390/children9111696.


References
1.
Razazizan N, Mirmoeini M, Daeichin S, Ghadiri K . Comparison of 25-hydroxy vitamin D, calcium and alkaline phosphatase levels in epileptic and non-epileptic children. Acta Neurol Taiwan. 2014; 22(3):112-6. View

2.
Attilakos A, Dinopoulos A, Paschalidou M, Tsirouda M, Karalexi M, Prasouli A . Long-term effect of levetiracetam monotherapy on haematological parameters in children with epilepsy: A prospective study. Epilepsy Res. 2018; 145:160-162. DOI: 10.1016/j.eplepsyres.2018.07.001. View

3.
Mansbach J, Ginde A, Camargo Jr C . Serum 25-hydroxyvitamin D levels among US children aged 1 to 11 years: do children need more vitamin D?. Pediatrics. 2009; 124(5):1404-10. PMC: 3765249. DOI: 10.1542/peds.2008-2041. View

4.
Krishnamoorthy G, Karande S, Ahire N, Mathew L, Kulkarni M . Bone metabolism alteration on antiepileptic drug therapy. Indian J Pediatr. 2009; 76(4):377-83. DOI: 10.1007/s12098-009-0005-5. View

5.
Turan M, Cayir A, Ozden O, Tan H . An examination of the mutual effects of valproic acid, carbamazepine, and phenobarbital on 25-hydroxyvitamin D levels and thyroid function tests. Neuropediatrics. 2013; 45(1):16-21. DOI: 10.1055/s-0033-1349226. View